BioHistory Moment: Food Additives Amendments passed
On September 6, 1958, The Food Additives Amendments were passed, requiring that food
additives, including preservatives, emulsifiers, and other functional additives,
be subject to premarket testing.
Today, the FDA must review the safety of food and color additives before manufacturers
and distributors can market them. To initiate this review, the FDA requires sponsors
to submit a petition or notification that includes test data demonstrating the
safety of the intended use of the substance.
 More...
Learn about University of Iowa Research Park BioVentures Center
The Research Park/BioVentures Center, also known as the University of Iowa’s Oakdale Campus, is conveniently located on
Highway 965 near Interstates 80 and 380 and U.S. Highways 16 and 218. The Park is in the fast-growing
community of Coralville, about 10 minutes from the main UI campus of Iowa City, 15 minutes from commercial
airlines at the Eastern Iowa Regional Airport in Cedar Rapids and 10 minutes from charter and corporate aircraft
at the Iowa City Municipal Airport.
Learn about biotechnology, medical device and pharmaceutical facilities available for sale,
lease or sublease in Ohio, regionally or nationwide.
More...
(Advertising)
|
|
|
Industry News...
Free News Release Posting & Archiving Service
- Celsion receives SBIR grant to expand Its technology platform Celsion has been awarded a Phase I Small SBIR grant from the NIH, to support the proposal, "New Thermal Sensitive Carboplatin Liposomes for Cancer". This funding will support the Company's efforts to develop its proprietary heat-activated liposomal technology in combination with carboplatin.
Celsion Corporation September 03, 2010
- Celgene officially notified of ANDA filing for REVLIMID(R) Celgene announced it has received a Paragraph IV Certification Letter advising that Natco Pharma Limited of Hyderabad, India, submitted an Abbreviated New Drug Application to the FDA. The application requests authorization to manufacture and market generic versions of REVLIMID(R) in the U.S.
Celgene Corporation September 03, 2010
- Tibotec seeks European Marketing Authorization for once-daily HIV treatment TMC278 Tibotec Pharmaceuticals announced its submission of a Marketing Authorisation Application to the European Medicines Agency for TMC278 (rilpivirine, as hydrochloride), an investigational non-nucleoside reverse transcriptase inhibitor for the treatment of HIV.
Tibotec Pharmaceuticals September 03, 2010
- European Commission issues positive decision for approval of Seroquel XR AstraZeneca announced the European Commission issued a positive decision for the approval of once-daily SEROQUEL XR Extended Release Tablets as an add-on treatment of major depressive episodes in patients with Major Depressive Disorder who had sub-optimal response to antidepressant monotherapy.
AstraZeneca September 02, 2010
- New England Journal of Medicine reports Xpert MTB/RIF a faster Tuberculosis test New England Journal of Medicine reports Xpert MTB/RIF a faster, more Cepheid announced that its Xpert(R) MTB/RIF test was the subject of a study published in the latest edition of the New England Journal of Medicine (NEJM), "Rapid Molecular Detection of Tuberculosis and Rifampin Resistance."
Cepheid September 02, 2010
More... | Submit News Release | Advertising...
|
New Job Postings...
Free Job Posting Trial Offer
More... |
Job Advertising...
| About Job Postings...
|
New Facilities Available...
More... |
Facility Advertising...
|
Upcoming Events...
 More... |
Submit Event |
Event Advertising...
|
|
Learn About Ohio's BioHistory
Why is there a life science industry in Ohio? Is the industry
growing? What do other states have?
Through Ohio BioHistory, you can learn about the scientists,
institutions, political leaders, and significant events that have shaped and are still shaping
the biotechnology, medical device and life science industry in Ohio.
More...
BioEvolution Posters
More...
September: Ovarian Cancer Awareness Month
In women age 35-74, ovarian cancer is the fifth leading cause of cancer-related deaths.
An estimated one woman in 58 will develop ovarian cancer during her lifetime. The
American Cancer Society estimates that in 2008, there will be 21,650 new cases of
ovarian cancer and 15,520 women will die from ovarian cancer.
The National Ovarian Cancer Coalition (NOCC) is dedicated to raising awareness and
increasing education about ovarian cancer. Established in 1995, the organization is
committed to improving the survival rate and quality of life for women with this cancer.
More...
BioFact
(1964) - Based on its success with IRRI, the Rockefeller Foundation initiates its second international research center, CIMMYT, the International Center for the Improvement of Maize and Wheat, in Mexico.
It's a Small World
|
| |
Anthrax Bacteria Colonies
| |
Science Quote
"There is no national science just as there is no national multiplication table; what is national is no longer science."
| - |
Anton Chekhov, Russian physician
|
|
(1860-1904)
|
|
